Patheon shares deflate on flat forecast

Article Abstract:

Patheon Inc. saw its share value decline by 18% after the company forecasted flat profits for the fiscal year ending October 31, 2001. Patheon shares fell to 10.95 Canadian dollars per share after dropping previously to 10.85 Canadian dollars per share.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code:

Partners' dispute hits Angiotech shares

Article Abstract:

Angiotech Pharmaceuticals Inc. saw its share value drop by an additional 11% on September 13, 2001. The company is caught amidst a drug-coated medical device dispute between its two research partners

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code:

Oncolytics Biotech rises on cancer virus news

Article Abstract:

With the announcement of promising news concerning its cancer treatment, Oncolytics Biotech Inc.'s shares rise five percent.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code: